This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucb Pharma Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Emre M Isin: Innovator in Pharmaceutical Chemistry
Introduction
Emre M Isin is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing various disorders through innovative chemical solutions.
Latest Patents
Emre M Isin holds a patent for "Substituted alkoxypyridinyl indolsulfonamides." This patent relates to alkoxy-substituted pyridinyl indolsulfonamides, which are identified as negative GPR17 modulators. These compounds have potential utility in the treatment of various GPR17 associated disorders. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Emre M Isin is currently associated with UCB Pharma GmbH, a leading global biopharmaceutical company. His role at UCB Pharma involves research and development of new therapeutic solutions. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Emre collaborates with various professionals in his field, including his coworker Laurent Provins. Their combined efforts contribute to the advancement of innovative solutions in pharmaceutical research.
Conclusion
Emre M Isin exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for complex disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile